A Call to Reduce Disparities, Build Trust in Clinical TrialsJun. 2, 2021Like no other time in history, scientists are now able to treat inherited diseases. But because the scientific and medical communities have not sufficiently engaged diverse communities of color, there is a danger of developing genetic medicine based on databases of information only from European Caucasians. Sounding this alarm was Eric Kmiec, Ph.D., director of […] The post A Call to Reduce Disparities, Build Trust in Clinical Trials appeared first on ChristianaCare News.
Meet DECODR: Affordable App Reveals Unintended Mutations at Site of CRISPR Gene RepairFeb. 17, 2021Scientists have developed an affordable, downloadable app that scans for potential unintended mistakes when CRISPR is used to repair mutations that cause disease. The app reveals potentially risky DNA alterations that could impede efforts to safely use CRISPR to correct mutations in conditions like sickle cell disease and cystic fibrosis. The development of the new […] The post Meet DECODR: Affordable App Reveals Unintended Mutations at Site of CRISPR Gene Repair appeared first on ChristianaCare News.- $1M Grant Awarded to Gene Editing Institute for Sickle Cell ResearchDec. 1, 2020Scientists at ChristianaCare’s Gene Editing Institute received a $1 million grant from the Lisa Dean Moseley Foundation to develop a novel gene therapy for inherited blood disorders including sickle cell disease, offering hope to nearly 100,000 Americans suffering from the disease who are disproportionately African American. Building on previous work that showed how gene editing efficiencies […] The post $1M Grant Awarded to Gene Editing Institute for Sickle Cell Research appeared first on ChristianaCare News.
- Sen. Carper Visits ChristianaCare’s Gene Editing InstituteOct. 14, 2020U.S. Sen. Tom Carper visited ChristianaCare's Gene Editing Institute. The Gene Editing Institute, based on ChristianaCare's Newark, Delaware campus, is a worldwide leader in CRISPR gene editing technology. research and education. The post Sen. Carper Visits ChristianaCare’s Gene Editing Institute appeared first on ChristianaCare News.
Future scientists can dig into CRISPR in a Box™Sep. 25, 2020In a groundbreaking partnership, ChristianaCare’s Gene Editing Institute, Delaware Technical Community College and Rockland Immunochemicals, Inc. will market and sell CRISPR in a Box globally. The post Future scientists can dig into CRISPR in a Box™ appeared first on ChristianaCare News.
Using CRISPR to launch a dual attack on COVID-19, health care disparities in DelawareJul. 29, 2020ChristianaCare researchers are evaluating the CRISPR-based SHERLOCK COVID-19 test to ensure greater accessibility of breakthroughs to underserved populations. The post Using CRISPR to launch a dual attack on COVID-19, health care disparities in Delaware appeared first on ChristianaCare News.
New CRISPR advance delivers a one-two punch to lung cancer cellsJul. 6, 2020A mutation unique to certain cancer tumors is a potential homing beacon for safely deploying CRISPR gene editing enzymes to disarm DNA that makes cancer cells resistant to treatment, while ignoring the gene in normal cells where it’s critical to healthy function. The post New CRISPR advance delivers a one-two punch to lung cancer cells appeared first on ChristianaCare News.
Federal guidelines will speed bench-to-bedside research and advance clinical trials using gene editing technologyMar. 3, 2020As laboratory breakthroughs using CRISPR gene editing technology advance from bench to bedside – including a lung cancer clinical trial from the Gene Editing Institute at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute – federal policies and guidelines to ensure safe, effective therapies have lagged behind. But last month they took a major […] The post Federal guidelines will speed bench-to-bedside research and advance clinical trials using gene editing technology appeared first on ChristianaCare News.
New tool for rapid analysis of CRISPR reveals frequent, unintended DNA changesDec. 10, 2019Amidst rising hopes for using CRISPR gene editing tools to repair deadly mutations linked to conditions like cystic fibrosis and sickle cell disease, a new study in the Nature journal Communications Biology describes an innovation that could accelerate this work by rapidly revealing unintended and potentially harmful changes introduced by the gene editing process. “We’ve […] The post New tool for rapid analysis of CRISPR reveals frequent, unintended DNA changes appeared first on ChristianaCare News.